Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Are you experienced in technical Translations? Are you open to work on site, in Madrid? Take a look! ORTEC ENGINEERING is the engineering subsidiary of ORTEC GROUP. Si desea saber un poco más sobre esta oportunidad,